ALEMBIC OLMESARTAN HCT 20/25 olmesartan medoxomil/hydrochlorothiazide 20/25 mg film-coated tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

olmesartan medoxomil, Quantity: 20 mg; hydrochlorothiazide, Quantity: 25 mg

Commercializzato da:

Alembic Pharmaceuticals Australia Pty Ltd

INN (Nome Internazionale):

Hydrochlorothiazide,Olmesartan medoxomil

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: hyprolose; magnesium stearate; hypromellose; purified water; microcrystalline cellulose; lactose monohydrate; titanium dioxide; iron oxide yellow; macrogol 4000

Via di somministrazione:

Oral

Confezione:

30

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Treatment of hypertension. Treatment should not be initiated with this fixed dose combination.

Dettagli prodotto:

Visual Identification: 20/25 mg film coated tablets are yellow film coated, oval shaped, biconvex tablets debossed with L400 on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2015-02-05